Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Rheum Dis
Hlavní autoři: Devauchelle-Pensec, Valérie, Berthelot, Jean Marie, Cornec, Divi, Renaudineau, Yves, Marhadour, Thierry, Jousse-Joulin, Sandrine, Querellou, Solène, Garrigues, Florent, De Bandt, Michel, Gouillou, Maelenn, Saraux, Alain
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2016
Témata:
Clinical and Epidemiological Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975852/
https://ncbi.nlm.nih.gov/pubmed/26929219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208742
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky